NEOGENOMICS INC — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: Bonello William (President, Informatics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-30	Common Stock	A	21400	—	Acquired	61873	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (10727.0)	10727	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (45370.0)	45370	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (41167.0)	41167	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (37514.0)	37514	Direct
Stock Option (Right to Buy)	$53.17	2028-03-02	Common Stock (24619.0)	24619	Direct

Footnotes

F1: On December 30, 2021, Mr. Bonello was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F3: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F4: On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F6: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.